Patent ID: 11918585
Assignee: INCYTE CORPORATION
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A

Claim 0:
1. A pharmaceutical formulation in solid oral dosage form comprising:
(a)N-(4-(4-amino-7-(1-isobutyrylpiperidin-4-yl)pyrrolo[2,1-f][1,2,4]triazin-5-yl)phenyl)-1-isopropyl-2,4-dioxo-3-(pyridin-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxamide (Compound I), or a pharmaceutically acceptable salt, solvate or hydrate thereof;
(b) an organic acid; and
(c) a surfactant;, wherein the pharmaceutical formulation comprises about 1 to about 100 mg of Compound I, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, on a free base basis.